SGLT2 Inhibitors & Aortic Valve Stenosis; Early vs. Later Ablation for Afib; Sports Participation by Athletes with Cardiac Abnormalities
In this week’s View, Dr. Eagle looks at the potential exposure-dependent protective effect of SGLT2 inhibitors on aortic valve stenosis progression. He then discusses the potential value of earlier ablation for atrial fibrillation versus later ablation. Finally, Dr. Eagle explores new guidance for sports participation by athletes with cardiac abnormalities.
X Links:
- Kim Eagle, MD, MACC keaglemd
Clinical Topics: Arrhythmias and Clinical EP, Congenital Heart Disease and Pediatric Cardiology, Heart Failure and Cardiomyopathies, Pericardial Disease, Prevention, Sports and Exercise Cardiology, Valvular Heart Disease, Implantable Devices, Genetic Arrhythmic Conditions, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Congenital Heart Disease, CHD and Pediatrics and Arrhythmias, CHD and Pediatrics and Prevention, Hypertension, Sports and Exercise and Congenital Heart Disease and Pediatric Cardiology
Keywords: Aortic Valve Stenosis, Sodium-Glucose Transporter 2 Inhibitors, Ablation, Atrial Fibrillation, Arrhythmias, Cardiac, Channelopathies, Coronary Vessels, Myocarditis, Heart Defects, Congenital, Heart Valve Diseases, Athletes, Pericarditis, Hypertension, Electrocardiography
